Closed

European partnership for the assessment of risks from chemicals (PARC)

HORIZON Programme Cofund Actions

Basic Information

Identifier
HORIZON-HLTH-2021-ENVHLTH-03-01
Programme
Partnerships in Health (2021)
Programme Period
2021 - 2027
Status
Closed (31094503)
Opening Date
June 21, 2021
Deadline
September 20, 2021
Deadline Model
single-stage
Budget
€200,000,000
Min Grant Amount
€200,000,000
Max Grant Amount
€200,000,000
Expected Number of Grants
1
Keywords
HORIZON-HLTH-2021-ENVHLTH-03-01HORIZON-HLTH-2021-ENVHLTH-03Analytical chemistryPublic and environmental healthToxicology

Description

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 2 ‘Living and working in a health-promoting environment’. To that end, the proposal under this topic should aim for delivering results that are directed, tailored towards and contributing to all of the following expected outcomes:

  • The EU is reinforced as an internationally recognised driver of innovation in chemicals risk assessment and thereby substantially contributing to the achievement of the Sustainable Development Goals related to chemicals;
  • EU and national chemicals risk assessment and management authorities rely on a sustainable Europe-wide research and innovation platform for chemicals risk assessment, as identified in the Council Conclusions[1] of June 2019 ‘Towards a Sustainable Chemicals Policy Strategy of the Union’ and in the ‘Chemicals Strategy for Sustainability’[2], to provide joint new knowledge and innovate risk assessment processes;
  • EU and national chemical risk assessment agencies and the scientific community enhance their collaboration and move towards ‘one substance – one assessment’ with shared evidence, tools and methodologies cutting across sectors;
  • The Common European Green Deal Data Space is empowered, by providing it with reliable, relevant, curated and FAIR[3] data on chemicals in line with the European Strategy for Data[4];
  • Synergies are established with relevant activities derived from other European Green Deal policy areas, such as the ‘Farm to Fork strategy’, the ‘Biodiversity Strategy for 2030’, the ‘8th Environment Action Programme’ and the ‘Zero Pollution Action Plan for Air, Water and Soil’, to understand and address their needs for research and innovation in chemicals risk assessment and ensure a better protection of the environment and human health from hazardous chemical exposures;
  • Public authorities and industry engaged in developing a circular economy, including better waste management, as defined in the EU’s ‘Industrial Strategy’[5] and the ‘New Circular Economy Action Plan’[6], are supported with innovation in chemicals risk assessment.
  • Workers are better protected from chemical risks as set out in the ‘EU Strategic Framework on Health and Safety at Work 2014-2020’[7] through better insight into exposures and health impacts and improved safety measures.
Scope:

Chemicals risk assessors and managers are faced with data and knowledge gaps and lack of tools and methods, to speed up and prioritise risk assessments and capture risks from existing and emerging substances across regulatory domains. The lack of available or accessible information increases the risk of ‘regrettable’ substitutions and slows down the design of safer chemicals. A diverse landscape of regulatory frameworks and actors carrying out risk assessment of chemicals for their specific purpose has resulted in a fragmented approach. Risks to human and environmental health are still in certain cases considered separately, while in most cases they are inherently interrelated.

To enable risk assessors and risk managers to respond to current and future challenges, the Partnership[8] should stimulate research and innovation in chemicals risk assessment by developing a collaborative network with public research entities. A common research and innovation programme should be established by national and EU risk assessors and risk managers in consultation with relevant stakeholders (academia, industry, associations and others).

Activities of the Partnership should be complementary and subsidiary to obligations under existing regulatory frameworks, and should coordinate with these as relevant. The Partnership should become a reference centre for research questions related to chemicals risk assessment, including those emerging from other Horizon Europe partnerships or missions. The Partnership is expected to establish relevant collaborations with other Horizon Europe partnerships and missions as set out in the working document on ‘Coherence and Synergies of candidate European partnerships under Horizon Europe’[9] as well as to explore collaborations with other relevant activities at EU and international level. The Partnership should align with EU-wide initiatives on open access and FAIR data[3].

The Partnership’s governance structure should engage upfront risk managers and risk assessors to coordinate, steer and frame the research and innovation activities, facilitate the use and uptake of the results in a regulatory context and contribute to a science based communication of the risk of chemicals. The Partnership’s governance and operational structures should also foster a dialogue on sustainability, beyond funding from EU research and innovation framework programmes, with political decision-makers and risk assessors.

Main blocks of activity:

1. Set-up and operate an EU-wide cross-disciplinary network to identify and agree on research and innovation needs and support research uptake into regulatory chemical risk assessment.

A dialogue and priority-setting process should be established, bringing together European regulatory entities and risk assessment agencies to develop a strategic research and innovation agenda for chemicals risk assessment in collaboration with the scientific community. This process should also facilitate access and uptake of new scientific knowledge that can contribute to regulatory science by policy-makers and risk assessors.

Relevant synergies should be fostered with other initiatives at national, EU or international level and targeted communication and dissemination should be implemented to ensure openness and transparency of this Partnership towards all concerned stakeholders. The Partnership should build on and extend the concept of National Hubs developed under the European Joint Programme on Human Biomonitoring, HBM4EU[11]. Targeted citizen actions should be envisaged to increase their understanding of risks related to exposure to chemicals and reinforce their trust in risk assessment and risk management processes.

2. Carry out joint EU research and innovation activities on identified priorities to support the current regulatory risk assessment processes and respond to emerging challenges.

The Partnership should drive innovation in environmental and human exposure assessment. . New tools and methods for environmental and human exposure monitoring, including in occupational settings, and to gather data on lifestyle and consumption behaviour, should be developed, validated and their harmonised use promoted. Biomarkers of effects in environment and in human should be developed as a proxy of environmental and health outcomes. Collaborations with existing programmes should be fostered; however, when required and relevant, the partnership can carry out monitoring and exposure assessment activities. This could entail monitoring of environmental media and human exposure to chemicals from various sources and exposure routes. For human biomonitoring, the Partnership should build on the results of HBM4EU and further exploit these as well as perform new studies for prioritised chemicals and regulatory questions. Moreover, human biomonitoring activities should be integrated in the wider exposure assessment and risk assessment contexts.

Toxicological or eco-toxicological studies to generate new data for chemical substances and mixtures relevant to public health (mechanistic, in silico, in vitro or in vivo), beyond the data required from industry under REACH or by other regulations, should be designed and performed, taking into account the Reduce-Refine-Replace (3Rs) principle and any regulatory requirements for their relevance. Novel methods for toxicological hazard assessment aligned with identified needs should be developed, and existing methods improved, including methods that can reliably screen (groups of) substances allowing to select the substances for which a full safety assessment is required. New Approach Methodologies (NAMs) should be integrated with classical experimental designs to improve hazard characterization and their regulatory acceptance promoted through validation or applicability studies.

The performance of current methodologies employed in regulatory risk assessment should be assessed to identify methodological knowledge gaps and R&I needs. Validation and standardisation of results and methods of the Partnership or from collaborating projects should be pursued, e.g. development of OECD Test Guidelines, to encourage their use in regulatory risk assessment. Integrated Approaches to Testing and Assessment (IATA), integrative exposure and exposure reconstruction models and practical approaches for regulatory risk assessment of single, aggregated or combined exposure should be developed and their regulatory uptake fostered. Causal associations between (combined) exposures to chemicals and health outcomes should be investigated.

3. Strengthen existing capacities and build EU-wide, transdisciplinary research and innovation platforms to support chemical risk assessment

A data policy in line with FAIR data principles, taking into account General Data Protection Regulation (GDPR) related challenges, should be developed and implemented in the Partnership for data management, harmonisation, interoperability and exchange. Building on accepted data formats and existing data platforms[12], solutions to collect, store, manage and permit access to new data generated by R&I activities in the partnership should be proposed. Access and linkage to existing data collections should be facilitated. Innovative methods for data analysis should be pursued, including uncertainty analysis, data mining, and machine learning.

Innovative approaches in chemical risk assessment should be investigated and, if validated, promoted including at least the following: 1) supporting the European Commission’s work on defining the Safe-and-Sustainable-by-Design concept and implementation criteria and proposing a toolbox to support the application of these criteria; 2) investigating how to further support the initial pilot study on an EU Early Warning System launched by the European Commission in 2019; and 3) making models and modelling approaches accessible and compliant with FAIR principles via an open source repository.

The Partnership should, in cooperation with appropriate EU and National reference laboratory networks, identify, and, when needed, enhance existing networks and develop new networks. These networks should aim at standardising methods, making available Quality Assurance/Quality Control (QA/QC) schemes and promoting the uptake of new methods and tools through training and peer-to-peer learning. In addition, specific training should be undertaken for different groups of stakeholders, including own partners, to ensure a wide use of data, methods, tools and models promoted by the Partnership.

Partner composition, geographical coverage and funding conditions:

The Partnership is open to all EU Member States as well as countries associated to Horizon Europe and will remain open to those wanting to join during the Partnership’s lifetime.

Beneficiaries should preferably be:

  • National institutions in charge of chemical risk assessment and carrying out related research and innovation activities.
  • Exceptionally, if the national risk assessors prefer not to participate as beneficiaries and manage a network of affiliated entities, other solutions can be envisaged but must be duly justified and, when to conditions for participating as affiliated entities exists, the national risk assessor may participate under such status.

To encourage national coordination, participation as beneficiary should be limited to two entities per country; the use of affiliated entities is thus strongly encouraged, when the conditions for participating as affiliated entity exist.

Affiliated entities are defined under the Horizon Europe Model Grant Agreement and, in this specific topic, should be:

  • Academia and research organisations that are part of the national networks on research for chemicals risk assessment and have established links to the risk-assessing institutions.
  • National risk assessors or government agencies in the exceptional case they will not be beneficiaries as mentioned above.

Depending on their individual legal and operational frameworks and in agreement with the relevant services of the European Commission (partner DGs), EU Agencies involved in chemicals risk assessment and/or producing knowledge on chemicals’ safety may also join the Partnership, e.g. as beneficiaries.

Collaboration with the European Commission's Joint Research Centre (JRC) should be considered to facilitate the sharing of chemical monitoring data in IPCHEM[13], and in other areas of mutual interest, such as (bio)monitoring, novel approaches for risk assessment including non-animal approaches, safe and sustainable design of chemicals, training and capacity building.

The expected duration of the partnership is seven years.

The Horizon Europe contribution will be limited to a maximum of 50% of the total eligible costs of the action with a maximum of EUR 200 million of EU contribution.

[1] https://www.consilium.europa.eu/en/press/press-releases/2019/06/26/council-conclusions-on-chemicals/

[2] https://ec.europa.eu/environment/strategy/chemicals-strategy_en

[3] FAIR data are data, which meet principles of findability, accessibility, interoperability, and reusability.

[4] https://ec.europa.eu/info/sites/info/files/communication-european-strategy-data-19feb2020_en.pdf

[5] https://ec.europa.eu/info/strategy/priorities-2019-2024/europe-fit-digital-age/european-industrial-strategy_en

[6] https://ec.europa.eu/environment/circular-economy/

[7] https://ec.europa.eu/social/main.jsp?catId=151

[8] https://ec.europa.eu/info/files/european-partnership-chemicals-risk-assessment_en

[9] https://ec.europa.eu/info/horizon-europe/european-partnerships-horizon-europe_en#synergies

[10] FAIR data are data, which meet principles of findability, accessibility, interoperability, and reusability.

[11] www.hbm4eu.eu

[12] Examples of relevant EC data platforms:

IPCHEM https://ipchem.jrc.ec.europa.eu/RDSIdiscovery/ipchem/index.html,

eChemPortal: https://www.echemportal.org/echemportal/.

[13] https://ipchem.jrc.ec.europa.eu/RDSIdiscovery/ipchem/index.html

Destination & Scope

Calls for proposals under this destination are directed towards the Key Strategic Orientation KSO-D ‘Creating a more resilient, inclusive and democratic European society’ of Horizon Europe’s Strategic Plan 2021-2024. Research and innovation supported under this destination should contribute to the impact area ‘A resilient EU prepared for emerging threats’ and in particular to the following expected impact, set out in the Strategic Plan for the health cluster: ‘living and working environments are health-promoting and sustainable thanks to better understanding of environmental, occupational, social and economic determinants of health’. In addition, research and innovation supported under this destination could also contribute to the following impact areas: ‘Good health and high quality accessible health care’, ‘Climate change mitigation and adaptation’, and Clean and healthy air, water and soil’.

The environment we live and work in is a major determinant of our health and well-being. It has direct or indirect beneficial or adverse impact on our health and well-being. Environmental factors are estimated to account for almost 20% of all deaths in Europe. Opinion surveys have shown that European citizens are concerned about the impact of pollution on their health. The impacting factors on both physical and mental health and well-being are not all identified nor their effects comprehensively understood and accounted for to support evidence-based policy- and decision-making. Furthermore, agreed methodologies to estimate health-related costs of exposure to environmental stressors are lacking.

Therefore, Destination 2 aims at filling knowledge gaps in the understanding of the impacts on our health and well-being of those environmental, occupational and socio-economic risk factors that have the most significant or widespread societal impacts. In this work programme, Destination 2 focuses on indoor and outdoor air pollution, chemicals, non-ionizing radiation (electromagnetic fields), urbanisation, climate and other environmental changes, socio-economic inequalities, and changing working environments. Furthermore, under this work programme a topic is dedicated to the creation of a European partnership for the assessment of risks from chemicals, which should establish the EU as an internationally recognised driver of innovative chemical risk assessment for an optimal protection of human health and the environment. The results will support the EU’s environment and health policies and overarching policy frameworks such as the European Green Deal, the Chemical Strategy for Sustainability, the 8th Environment Action Programme, the EU Strategic Framework on Health and Safety at Work as well as the WHO European Environment and Health Process (EHP).

Strong collaborations across sectors and with other Horizon Europe clusters dealing with issues such as agriculture, food, environment, climate, mobility, security, urban planning, social inclusion and gender will be needed to ensure that maximal societal benefits are reached. Thus, in view of increasing the impact of EU investments under Horizon Europe, the European Commission welcomes and supports cooperation between EU-funded projects to enable cross-fertilisation and other synergies. This could range from networking to joint activities such as the participation in joint workshops, the exchange of knowledge, the development and adoption of best practices, or joint communication activities. Opportunities for potential synergies exist between projects funded under the same topic but also between other projects funded under another topic, cluster or pillar of Horizon Europe (but also with ongoing projects funded under Horizon 2020). In particular, this could involve projects related to European health research infrastructures (under pillar I of Horizon Europe), the EIC strategic challenges on health and EIT-KIC Health (under pillar III of Horizon Europe), or in areas cutting across the health and other clusters (under pillar II of Horizon Europe).

All topics are open to international collaboration to address global environment and health challenges.

Expected impacts:

Proposals for topics under this destination should set out a credible pathway to contributing to living and working in a health-promoting environment, and more specifically to one or several of the following impacts:

  • Policy-makers and regulators are aware and well informed about environmental, socio-economic and occupational risk factors as well as health-promoting factors across society;
  • Environmental, occupational, social, economic, fiscal and health policies and practices at the EU, national and regional level are sustainable and based on solid scientific evidence. These include overarching policy frameworks such as the European Green Deal, the Chemical Strategy for Sustainability, the 8th Environment Action Programme, the EU Strategic Framework on Health and Safety at Work and the European Environment and Health Process led by the World Health Organization;
  • The upstream determinants of disease - related to choices in energy generation, agricultural practices, industrial production, land use planning, built environment and construction - are known, understood and reduced;
  • The health threats and burden resulting from hazardous chemicals and air, water and soil pollution and contamination is reduced, so that the related number of deaths and illnesses is substantially reduced by 2030;
  • Living and working environments in European cities and regions are healthier, more inclusive, safer, resilient and sustainable;
  • The adaptive capacity and resilience of populations and health systems in the EU to climate and environmental change-related health risks is strengthened;
  • Citizens’ health and well-being is protected and promoted, and premature deaths, diseases and inequalities related to environmental pollution and degradation are prevented;
  • Citizens understand better complex environment and health issues, and effective measures to address them and support related policies and regulations.

Eligibility & Conditions

General conditions

General conditions

1. Admissibility conditions: described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

 

2. Eligible countries: described in Annex B of the Work Programme General Annexes.

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding to support its participation in projects funded under the Health cluster.

 

3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.

 

4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.

The granting authority can fund a maximum of one project.

Award criteria, scoring and thresholds are described in Annex D of the Work Programme General Annexes.

Submission and evaluation processes are described in Annex F of the Work Programme General Annexes and the Online Manual.

Indicative timeline for evaluation and grant agreement: described in Annex F of the Work Programme General Annexes.

Funding rate will be 50%. This is justified by the pooling of proposers' in-kind contributions and in-house activities.

 

6. Legal and financial set-up of the grants: described in Annex G of the Work Programme General Annexes.

 

Specific conditions

7. Specific conditions: described in the specific topic of the Work Programme.

Support & Resources

Online Manual is your guide on the procedures from proposal submission to managing your grant.

Horizon Europe Programme Guide contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.

Funding & Tenders Portal FAQ – find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.

Research Enquiry Service – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.

Enterprise Europe Network – contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.

IT Helpdesk – contact the Funding & Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.

European IPR Helpdesk assists you on intellectual property issues.

CEN-CENELEC Research Helpdesk and ETSI Research Helpdesk –  the European Standards Organisations advise you how to tackle standardisation in your project proposal.  

The European Charter for Researchers and the Code of Conduct for their recruitment– consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.

Partner Search Services help you find a partner organisation for your proposal.

 

Latest Updates

Last Changed: February 1, 2022

We recently informed the applicants about the evaluation results for their proposals submitted under this call. The results of the evaluation are as follows:

  • Number of proposals submitted (including proposals transferred from or to other calls): 1
  • Number of inadmissible proposals: 0
  • Number of ineligible proposals: 0
  • Number of above-threshold proposals: 1
  • Total budget requested for above-threshold proposals: EUR 200.000.000
Last Changed: February 1, 2022

We recently informed the applicants about the evaluation results for their proposals submitted under this call. The results of the evaluation are as follows:

  • Number of proposals submitted (including proposals transferred from or to other calls): 1
  • Number of inadmissible proposals: 0
  • Number of ineligible proposals: 0
  • Number of above-threshold proposals: 1
  • Total budget requested for above-threshold proposals: EUR 200.000.000
Last Changed: October 4, 2021

Call HORIZON-HLTH-2021-ENVHLTH-03 closed on 21 September 2021. 1 proposal was submitted. The breakdown per topic is:

  • HORIZON-HLTH-2021-ENVHLTH-03-01: 1 proposal

Evaluation results are expected to be communicated on Friday 28 January 2022 at the earliest.

Last Changed: October 4, 2021

Call HORIZON-HLTH-2021-ENVHLTH-03 closed on 21 September 2021. 1 proposal was submitted. The breakdown per topic is:

  • HORIZON-HLTH-2021-ENVHLTH-03-01: 1 proposal

Evaluation results are expected to be communicated on Friday 28 January 2022 at the earliest.

Last Changed: August 20, 2021

Although the submission of the document titled ‘Template for essential information to be provided for proposals including clinical trials/studies/investigations/cohorts’ is not mandatory for the call topic you have accessed, if your proposal includes a clinical study (as it is defined in the template), you are encouraged to complete and submit this template as part of your grant application. Please disregard the second footnote in the template.

Last Changed: June 23, 2021
The submission session is now available for: HORIZON-HLTH-2021-ENVHLTH-03-01(HORIZON-COFUND)
European partnership for the assessment of risks from chemicals (PARC) | Grantalist